OMECOOL

This brand name is authorized in Nigeria.

Active ingredients

The drug OMECOOL contains one active pharmaceutical ingredient (API):

1	Omeprazole UNII KG60484QX9 - OMEPRAZOLE
	Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.
	Read more about Omeprazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3703	Capsule	Omecool Capsules CAP 20 mg 2 x 7's (in PVC-Alu blisters)	Oral Capsule 54 CMS-PP-346858 OMECOOL CAPSULES OMEPRAZOLE BP 20MG EACH HARD GELATIN CAPSULES CONTAINS OMEPRAZOLE BP 20MG LIST OF EXCIPIENTS lactose monohydrate, sodium starch glycolate, sodium stearate, sodium stearyl fumarate. B4-3703 Drugs Imported Products 2X7 Prescription Only Medicine (POM) 7/27/2023 SUITELIFE PHARMACEUTICALS LTD, 4 ayo davis close off ekolonu street, surulere, lagos 8129419809 suitelifepharma@yahoo.com SSM FORMULATIONS PRIVATE LIMITED, SURVEY NO. 11/1, MOUZA ASHTI, HINGANGHAT 442301, MAHARASHTRA, INDIA., India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC01	Omeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3703